Hyperleukotrieneuria in patients with allergic and inflammatory disease.
暂无分享,去创建一个
N. Higashi | M. Taniguchi | H. Mita | K. Akiyama | E. Ono
[1] N. Higashi,et al. Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[2] N. Higashi,et al. Increase in inflammatory mediator concentrations in exhaled breath condensate after allergen inhalation. , 2008, The Journal of allergy and clinical immunology.
[3] N. Higashi,et al. Increased urinary leukotriene E4 concentration in patients with eosinophilic pneumonia , 2008, European Respiratory Journal.
[4] M. Taniguchi,et al. Salicylamide‐induced anaphylaxis: increased urinary leukotriene E4 and prostaglandin D2 metabolite , 2008, Allergy.
[5] N. Higashi,et al. Role of cysteinyl-leukotrienes in the pathogenesis of nasal polyposis in patients with asthma , 2007 .
[6] F. Simons,et al. Risk assessment in anaphylaxis: current and future approaches. , 2007, The Journal of allergy and clinical immunology.
[7] M. Taniguchi,et al. Quantification of leukotriene B4 glucuronide in human urine. , 2007, Prostaglandins & other lipid mediators.
[8] Michael A Kaliner,et al. The diagnosis and management of sinusitis: a practice parameter update. , 2005, The Journal of allergy and clinical immunology.
[9] V. Cottin,et al. Eosinophilic pneumonias , 2005, Allergy.
[10] C. Bachert,et al. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. , 2005, The Journal of allergy and clinical immunology.
[11] Joint Task Force on Practice Parameters. The diagnosis and management of anaphylaxis: an updated practice parameter. , 2005, The Journal of allergy and clinical immunology.
[12] R. Nicklas. The diagnosis and management of anaphylaxis , 2005 .
[13] A. Higashi,et al. Urinary eicosanoid and tyrosine derivative concentrations in patients with vasculitides. , 2004, Journal of Allergy and Clinical Immunology.
[14] S. Dahlén,et al. Measuring quality of life in patients with sleep apnoea: whose life is it anyway? , 2004, Thorax.
[15] M. Malice,et al. Increase in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitation , 2004, Thorax.
[16] A. Higashi,et al. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis. , 2004, The Journal of allergy and clinical immunology.
[17] R. Bush,et al. Alternaria-induced asthma. , 2004, The Journal of allergy and clinical immunology.
[18] Hiroshi Tanaka,et al. High dose of inhaled fluticasone reduces high levels of urinary leukotriene E4 in the early morning in mild and moderate nocturnal asthma. , 2003, Chest.
[19] N. Higashi,et al. Nasal blockage and urinary leukotriene E4 concentration in patients with seasonal allergic rhinitis , 2003, Allergy.
[20] Keiko Saito,et al. The Roles of Cysteinyl Leukotrienes in Eosinophilic Inflammation of Asthmatic Airways , 2003, International Archives of Allergy and Immunology.
[21] H. Frierson,et al. Cysteinyl leukotriene expression in chronic hyperplastic sinusitis-nasal polyposis: importance to eosinophilia and asthma. , 2003, The Journal of allergy and clinical immunology.
[22] Masashi Kobayashi,et al. Leukotriene C4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma. , 2002, The Journal of allergy and clinical immunology.
[23] R. Panettieri. Cellular and molecular mechanisms regulating airway smooth muscle proliferation and cell adhesion molecule expression. , 1998, American journal of respiratory and critical care medicine.
[24] Dahlén. Lipid mediator pathways in the lung: leukotrienes as a new target for the treatment of asthma , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[25] M. Kumlin,et al. Urinary excretion of inflammatory mediators during allergen‐induced early and late phase asthmatic reactions , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[26] Mita,et al. Correlation among urinary eosinophil protein X, leukotriene E4, and 11‐dehydrothromboxane B2 in patients with spontaneous asthmatic attack , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[27] S. Dahlén,et al. Can asthma be studied in the urine? , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[28] H. Mita,et al. Urinary excretion of leukotriene E4 and 11-dehydrothromboxane B2 in patients with spontaneous asthma attacks. , 1997, International archives of allergy and immunology.
[29] H. Mita,et al. Efficient method for the quantitation of urinary leukotriene E4: extraction using an Empore C18 disk cartridge. , 1997, Journal of chromatography. B, Biomedical sciences and applications.
[30] H. Mita,et al. Urinary leukotriene E4 and 11‐dehydrothromboxane B2 in patients with aspirin‐sensitive asthma , 1997, Allergy.
[31] E. Israel,et al. Diurnal variation of urinary leukotriene E4 and histamine excretion rates in normal subjects and patients with mild-to-moderate asthma. , 1995, The Journal of allergy and clinical immunology.
[32] W. Henderson. The Role of Leukotrienes in Inflammation , 1994, Annals of Internal Medicine.
[33] T. Lee,et al. Urinary leukotriene E4 in bronchial asthma. , 1992, The European respiratory journal.
[34] A. Togias,et al. The role of leukotrienes in allergic rhinitis: a review. , 1991, The American review of respiratory disease.
[35] J. Zakrzewski,et al. The biotransformation in vitro of cysteinyl leukotrienes in blood of normal and asthmatic subjects. , 1989, Prostaglandins.
[36] M. Okuda,et al. The role of leukotriene D4 in allergic rhinitis. , 1988, Annals of allergy.
[37] M. Underner,et al. [Role of the leukotrienes in asthma]. , 1986, Allergie et immunologie.
[38] H. Bisgaard,et al. Effect of leukotriene D4 on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humans , 1986, Clinical allergy.
[39] G. Shackelford,et al. Chronic eosinophilic pneumonia. , 1971, Radiology.
[40] C. Carrington,et al. THE EOSINOPHILIC PNEUMONIAS , 1969, Medicine.
[41] W. Alberts. Eosinophilic Lung Diseases , 2009 .
[42] A. Mori,et al. Treatment for Churg-Strauss syndrome: induction of remission and efficacy of intravenous immunoglobulin therapy. , 2007, Allergology international : official journal of the Japanese Society of Allergology.
[43] J. Drazen. Leukotrienes in asthma. , 2003, Advances in experimental medicine and biology.
[44] D. Woodward,et al. Studies on leukotriene D4 as an eosinophil chemoattractant. , 1991, Drugs under experimental and clinical research.